{
  "id": 11408612,
  "title": "Pfizer Is Down 34% Over the Last 5 Years. Here's Why Its 6% Dividend Yield Might Finally Be Worth the Risk.",
  "url": "https://urgent.news/2026/10/02/pfizer-is-down-34-over-the-last-5-years-heres-why-its-6-dividend-11408612",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-02T08:03:00.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/investing/2026/10/02/pfizer-is-down-xx-over-the-last-5-years-heres-why/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": "Pfizer's stock price has plummeted by 34% over the past five years, leading to a 6% dividend yield that has caught the attention of investors seeking high yields. While a high dividend yield may seem attractive, a falling stock price often indicates underlying business troubles. Pfizer has been grappling with declining demand for its coronavirus products and losing exclusivity on several blockbuster drugs. The company implemented a cost realignment plan, which was a positive development, but such measures typically require time and may not guarantee success in achieving key goals.",
  "summary": "Pfizer has been going through a period of transition.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Nasdaq Markets",
        "title": "Pfizer Is Down 34% Over the Last 5 Years. Here's Why Its 6% Dividend Yield Might Finally Be Worth the Risk.",
        "url": "https://urgent.news/2026/10/02/pfizer-is-down-34-over-the-last-5-years-heres-why-its-6-dividend",
        "published": "2026-10-02T08:23:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}